Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.8.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Feb. 28, 2018
Feb. 28, 2017
Cash Flows from Operating Activities:    
Net (Loss) Income $ (3,220,659) $ 186,752
Adjustments to reconcile net loss (income) to cash provided by (used in) operating activities:    
Depreciation and amortization 13,579 21,942
Change in allowance for bad debts 4,091 (9,931)
Loss on write off of fixed assets 782 0
Deferred financing fees amortization 139,201 31,567
Stock based compensation 32,478 27,392
Deferred income taxes 3,107,655 98,701
Change in Operating Assets & Liabilities:    
Decrease (Increase) in accounts receivable 142,021 (427,416)
(Increase) Decrease in inventory (349,159) 221,594
(Increase) in prepaid expenses and sundry receivables (244,137) (183,778)
Decrease in prepaid expenses and refundable income tax 2,674 2,938
Decrease in other assets (80) 0
Increase (Decrease) in accounts payable and accrued liabilities 601,344 (477,495)
(Decrease) in income tax payable 0 (20,000)
Net Cash Provided by (Used in) Operating Activities 229,950 (527,734)
Cash Flows from Investing Activities:    
Acquisition of property and equipment (22,107) (14,682)
Net Cash (Used in) Investing Activities (22,107) (14,682)
Cash Flows from Financing Activities:    
Payments on line of credit (2,016,355)  
Proceeds from line of credit, net 0 265,859
Proceeds from note payable 1,500,000 0
Proceeds from exercise of warrant 1,426,500 0
Payment of deferred financing fees (130,000) 0
Payments for capital lease obligations 0 (895)
Net Cash Provided by Financing Activities 780,145 264,964
Net Increase (Decrease) in Cash and Cash Equivalents 987,988 (277,452)
Cash and Cash Equivalents at Beginning of Period 140,243 309,280
Cash and Cash Equivalents at End of period 1,128,231 31,828
Cash paid during the period for:    
Interest 113,785 151,162
Income taxes $ 0 $ 31,000